The Inflation Reduction Act, signed into law in August 2022, enacted significant changes in the way the government treats ...
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market ...
Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than ...
Universities and hospitals are repurposing existing drugs through late-stage trials with funded costs up to 90% lower than ...
The Medication Affordability and Patent Integrity Act would create new regulatory burdens on biotech companies, making it harder and taking longer to develop new treatments, while doing nothing to ...
How do they come up with the brand names for prescription drugs? The brand name drug Lyrica sounds nothing like the actual chemical compound pregabalin. How much do they try to craft the name so it ...
For scientists who are involved in drug discovery, failure is part of the job. Less than 15% of drug candidates make it to market from the laboratory. Most drugs don’t get through clinical trials ...
Industries from semiconductors to fiber-optic cables stand to benefit from space research and manufacturing, but experts told CNBC that medicine could see the most immediate disruption. A flurry of ...
Monday - Friday, 6:00 - 7:00 PM ET AstraZeneca CEO Pascal Soriot said artificial intelligence is helping the company develop medicines faster, identify promising drug targets, and improve the odds of ...
The US Supreme Court raised the bar for branded pharmaceutical companies seeking to sue over a competitor’s generic versions of their drugs that are marketed using what’s called a skinny label. The ...
WASHINGTON, June 4 (Reuters) - Drugmaker Hikma's (HIK.L), opens new tab generic version of Amarin Pharma's (AMRN.O), opens new tab cardiovascular medication Vascepa did not infringe Amarin's patents, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results